Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Akamatsu S, Terada N, Miyazawa Y, Narita S, Haba R, Sugimoto M. Tohi Y, et al. Among authors: shiga k. Jpn J Clin Oncol. 2023 Oct 4;53(10):984-990. doi: 10.1093/jjco/hyad088. Jpn J Clin Oncol. 2023. PMID: 37496400
The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.
Tohi Y, Kato T, Matsumoto R, Shinohara N, Shiga K, Yokomizo A, Nakamura M, Kume H, Mitsuzuka K, Sasaki H, Egawa S, Matsumura M, Hashine K, Inokuchi J, Eto M, Baba H, Ichikawa T, Kinoshita H, Matsuda T, Kakehi Y, Sugimoto M. Tohi Y, et al. Among authors: shiga k. Int J Clin Oncol. 2020 Dec;25(12):2107-2114. doi: 10.1007/s10147-020-01761-3. Epub 2020 Aug 8. Int J Clin Oncol. 2020. PMID: 32770439
The prognosis and the impact of radiotherapy in clinically regional lymph node-positive prostate cancer: Which patients are candidates for local therapy with radiation?
Ieiri K, Shiota M, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Iwai H, Shiga KI, Yokomizo A, Yoshitake T, Shioyama Y, Ishigami K, Terashima H, Eto M. Ieiri K, et al. Among authors: shiga ki. Urol Oncol. 2020 Dec;38(12):931.e1-931.e7. doi: 10.1016/j.urolonc.2020.08.018. Epub 2020 Sep 6. Urol Oncol. 2020. PMID: 32900626
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.
Hirama H, Sugimoto M, Miyatake N, Kato T, Venderbos LDF, Remmers S, Shiga K, Yokomizo A, Mitsuzuka K, Matsumoto R, Osawa T, Abe T, Sasaki H, Egawa S, Ninomiya I, Hashine K, Roobol MJ, Kakehi Y. Hirama H, et al. Among authors: shiga k. World J Urol. 2021 Jul;39(7):2491-2497. doi: 10.1007/s00345-020-03494-4. Epub 2020 Oct 20. World J Urol. 2021. PMID: 33079252
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Yamashita T, Shiota M, Machidori A, Kobayashi S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Yamashita T, et al. Among authors: shiga ki. Cancer Invest. 2021 Mar;39(3):251-256. doi: 10.1080/07357907.2020.1871486. Epub 2021 Jan 14. Cancer Invest. 2021. PMID: 33393849 Clinical Trial.
474 results